Rina & Jean chat about how the venue and signage for UK pharma meetings can give a misleading impression. Case discussed is Case AUTH/3644/5/22 & AUTH/3694/10/22.

Patient case studies can be used really well in a variety of ways by different functions within pharma. Case mentioned is Case AUTH/3503/4/21.

Further information in this article: https://globalforum.diaglobal.org/issue/may-2023/patient-case-studies-when-and-how-to-use-them/

Rina & Jean discuss why and how medical education could mention medicine - the pros and the cons, mentioning the results of a LinkedIn poll and Case AUTH/3244/9/19.

Who, why, when and how should UK pharma compliantly engage patients to provide a range of services? We provide clarity in just a few minutes.

How should we handle questions like this? Say no (there could be cake involved!!!)? Or say yes? Which questions should we be asking to be helpful, constructive and compliant?

Pharma feel nervous when engaging social media influencers, even though they can have a phenomenal impact. There's a lot to consider, so Rina & Jean chat through top-line principles so you can start gaining compliance confidence.

Rina & Jean discuss why, who, what and how email consent can comply with the ABPI Code.

What are the FIVE scenarios for when the UK Code applies to Global? Why is this important?

Rina and Jean discuss a no breach of the ABPI Code for Teva for how their website was accessed (Case 3641/4/22).

Rina and Jean discuss a breach of the ABPI Code for AstraZeneca, because of how an employee used LinkedIn (Case 3599/1/22).